Comerica Securities’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-188
| Closed | -$19.5K | – | 592 |
|
|
2022
Q4 | $19.5K | Buy |
+188
| New | +$19.5K | ﹤0.01% | 918 |
|
|
2022
Q1 | – | Sell |
-5,861
| Closed | -$518K | – | 492 |
|
|
2021
Q4 | $518K | Sell |
5,861
-164
| -3% | -$14.5K | 0.03% | 323 |
|
|
2021
Q3 | $466K | Buy |
6,025
+435
| +8% | +$33.6K | 0.03% | 322 |
|
|
2021
Q2 | $466K | Buy |
5,590
+27
| +0.5% | +$2.25K | 0.04% | 319 |
|
|
2021
Q1 | $420K | Sell |
5,563
-354
| -6% | -$26.7K | 0.03% | 343 |
|
|
2020
Q4 | $519K | Sell |
5,917
-68
| -1% | -$5.97K | 0.04% | 294 |
|
|
2020
Q3 | $455K | Buy |
5,985
+185
| +3% | +$14.1K | 0.04% | 290 |
|
|
2020
Q2 | $715K | Sell |
5,800
-171
| -3% | -$21.1K | 0.07% | 224 |
|
|
2020
Q1 | $505K | Sell |
5,971
-570
| -9% | -$48.2K | 0.06% | 242 |
|
|
2019
Q4 | $553K | Buy |
6,541
+222
| +4% | +$18.8K | 0.05% | 273 |
|
|
2019
Q3 | $426K | Buy |
6,319
+1,552
| +33% | +$105K | 0.04% | 296 |
|
|
2019
Q2 | $408K | Buy |
4,767
+1,285
| +37% | +$110K | 0.04% | 300 |
|
|
2019
Q1 | $309K | Buy |
3,482
+285
| +9% | +$25.3K | 0.03% | 336 |
|
|
2018
Q4 | $272K | Buy |
3,197
+617
| +24% | +$52.5K | 0.04% | 333 |
|
|
2018
Q3 | $250K | Buy |
2,580
+295
| +13% | +$28.6K | 0.03% | 376 |
|
|
2018
Q2 | $215K | Buy |
+2,285
| New | +$215K | 0.03% | 386 |
|